Other reports indicated that knocking down CCT8 significantly reduced CDK2 levels in hepatocellular carcinoma (HCC), suggesting substrate specificity variations among CCT subunits, the reasons for which remain unclear and warrant further investigation. Here, FLVCR2 is linked to hepatocellular carcinoma.